Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology
靶向特定 MicroRNA 缓解阿尔茨海默病病理学
基本信息
- 批准号:10666871
- 负责人:
- 金额:$ 67.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated RegionsAbeta clearanceAdultAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAstrocytesAutophagocytosisBehaviorBindingBrainCellsChronicDataDefectDementiaDepositionDeteriorationDown-RegulationEquilibriumEukaryotic CellExposure toGenetic TranscriptionHomeostasisHumanHyperactivityITGAM geneImmuneImpaired cognitionImpairmentIn VitroIndividualIngestionInjectionsKnowledgeMannoseMediatingMemoryMemory LossMicroRNAsMicrogliaModelingMolecularMusNerve DegenerationNeuronsPeptidesPhasePreventive measureProcessProductionProteinsPublishingReportingRoleSamplingSenile PlaquesSignal PathwaySirolimusTestingTherapeutic InterventionTissuesTranscriptUntranslated RNAUp-RegulationVacuoleabeta accumulationabeta depositionage relatedbrain cellexperimental studyextracellularhuman diseaseimprovedin vivoinhibition of autophagymembermouse modelnanolabelnanoparticleneuroprotectionneurotoxicitynew therapeutic targetnovel strategiespreventreceptorresponsesextau Proteinstherapeutic evaluationtherapeutic targettranscription factor
项目摘要
Targeting microglia to alleviate Alzheimer’s Disease pathobiology
Summary
Alzheimer’s disease (AD) is the most common cause of age-related dementia leading to irreversible
neurodegeneration and cognitive decline with no cure or effective preventive measures. Autophagy is a
conserved, cell response found in all eukaryotic cells. Several studies in AD showed that autophagy activity is
compromised in neuronal cells and suggested that this leads to reduced clearance of amyloid-β (Aβ) and
neurotoxicity. Few reports examined autophagy activity in the AD brain and suggested that autophagy is
dysfunctional in neurons, however, the contribution of autophagy in microglia, the immune cell of the brain, is
unclear. Our newly generated data that was recently published show that autophagy is impaired in adult microglia
from AD mice. More importantly, we found that a specific microRNA (miRNA), that targets several autophagy
molecules, is upregulated in the brain of AD patients when compared to non-AD individuals, as well as in the
brain and microglia-derived from an AD mouse model. Increased expression of this specific miRNA in the AD
brain leads to down-regulation of autophagy effectors, which is then responsible for reduced clearance of Aβ by
microglia. In Aim 1, we will determine the mechanism underlying elevated expression of the miR. In Aim 2, we
will investigate the functional consequences of reducing this miR in the brain of AD mouse and the mechanism
by which the microRNA is upregulated in AD brain. We will determine the behavior of microglia isolated from
treated mice. These experiments will be performed using the AD mouse model 5XFAD and human samples from
AD and non-AD patients. Our proposal will characterize a novel drug target and mode of delivery for AD.
靶向小胶质细胞缓解阿尔茨海默病病理学
概括
阿尔茨海默病 (AD) 是导致与年龄相关的痴呆症的最常见原因,导致不可逆转的痴呆症
自噬是一种无法治愈或有效预防措施的神经退行性疾病和认知能力下降。
在所有真核细胞中发现的保守的细胞反应,AD 的多项研究表明自噬活性是存在的。
神经元细胞受到损害,表明这会导致淀粉样蛋白-β (Aβ) 的清除率降低,
很少有报告检查 AD 大脑中的自噬活性并表明自噬是
然而,神经元功能失调,小胶质细胞(大脑的免疫细胞)中自噬的贡献是
我们最近发布的新生成的数据表明,成人小胶质细胞的自噬受到损害。
更重要的是,我们发现了一种针对多种自噬的特定 microRNA (miRNA)。
与非 AD 个体相比,AD 患者的大脑中的分子,以及在 AD 患者的大脑中表达上调。
AD 小鼠模型中的大脑和小胶质细胞中这种特定 miRNA 的表达增加。
大脑导致自噬效应子下调,从而导致 Aβ 清除率降低
在目标 1 中,我们将确定 miR 表达升高的机制。
将研究减少AD小鼠大脑中这种miR的功能后果及其机制
通过这种方式,microRNA 在 AD 大脑中被上调,我们将确定从中分离出的小胶质细胞的行为。
这些实验将使用 AD 小鼠模型 5XFAD 和来自人类的样本进行。
AD 和非 AD 患者的提案将描述 AD 的新药物靶点和给药方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amal O Amer其他文献
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis
Caspase-4/11 通过促进炎症和血栓形成而加剧 SARS-CoV-2 感染的疾病严重程度
- DOI:
10.1101/2021.09.24.461743 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Mostafa Eltobgy;Ashley N. Zani;A. Kenney;Shady Z K Estfanous;Eunsoo Kim;Asmaa Badr;Cierra Carafice;Kylene P. Daily;Owen Whitham;Maciej Pietrzak;Amy Webb;Jeffrey Kawahara;Adrian C. Eddy;Parker J Denz;Mijia Lu;K. Mahesh;M. Peeples;Jianrong Li;Jian Zhu;Jianwen Que;Richard T Robinson;Oscar Rosas Mejia;R. Rayner;Luanne Hall;S. Seveau;M. Gavrilin;Andrea Tedeschi;Santiago Partida;Frank Roberto;Emily A. Hemann;Eman Abdelrazik;Adriana Forero;S. Nimjee;P. Boyaka;E. Cormet;J. Yount;Amal O Amer - 通讯作者:
Amal O Amer
Amal O Amer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amal O Amer', 18)}}的其他基金
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections
SARS-CoV-2 感染中的肺和心脏病病理机制
- 批准号:
10649990 - 财政年份:2023
- 资助金额:
$ 67.46万 - 项目类别:
Rescue of CF phagocyte function with CFTR modulator therapy
CFTR 调节剂治疗拯救 CF 吞噬细胞功能
- 批准号:
10445615 - 财政年份:2022
- 资助金额:
$ 67.46万 - 项目类别:
Resue of CF phagocyte function with CFTR modulator therapy
CFTR调节剂治疗对CF吞噬细胞功能的恢复
- 批准号:
10797778 - 财政年份:2022
- 资助金额:
$ 67.46万 - 项目类别:
Host Responses to the Pore-Forming Toxin Listeriolysin O
宿主对成孔毒素李斯特菌溶血素 O 的反应
- 批准号:
10376220 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
Susceptibility determinants to Legionella pneumophila infection in smokers
吸烟者嗜肺军团菌感染的易感性决定因素
- 批准号:
10374758 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
Host Responses to the Pore-Forming Toxin Listeriolysin O
宿主对成孔毒素李斯特菌溶血素 O 的反应
- 批准号:
10589094 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY
非典型炎症小体在先天免疫中的作用
- 批准号:
10427453 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY
非典型炎症小体在先天免疫中的作用
- 批准号:
10625363 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY
非典型炎症小体在先天免疫中的作用
- 批准号:
10310743 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
Mechanistic basis of inflammation in Alzheimers Disease
阿尔茨海默病炎症的机制基础
- 批准号:
10259772 - 财政年份:2020
- 资助金额:
$ 67.46万 - 项目类别:
相似海外基金
MicroRNA Mouse Models and Alzheimer’s Disease
MicroRNA 小鼠模型和阿尔茨海默病
- 批准号:
10526166 - 财政年份:2022
- 资助金额:
$ 67.46万 - 项目类别:
Neurobiological significance of Aqp4 stop codon readthrough
Aqp4 终止密码子通读的神经生物学意义
- 批准号:
10409864 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
MiR-193a-5p as a Regulator of Intersectin1-short and Clathrin-Mediated Endocytosis in Alzheimer's Disease.
MiR-193a-5p 作为阿尔茨海默病中 Intersectin1-short 和网格蛋白介导的内吞作用的调节剂。
- 批准号:
10288636 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
MiR-193a-5p as a Regulator of Intersectin1-short and Clathrin-Mediated Endocytosis in Alzheimer's Disease.
MiR-193a-5p 作为阿尔茨海默病中 Intersectin1-short 和网格蛋白介导的内吞作用的调节剂。
- 批准号:
10480814 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别:
Neurobiological significance of Aqp4 stop codon readthrough
Aqp4 终止密码子通读的神经生物学意义
- 批准号:
10605249 - 财政年份:2021
- 资助金额:
$ 67.46万 - 项目类别: